Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Dermatologic 1CNS 1Breast 1

Conditions

Brain Neoplasms 8Glioblastoma 4Meningioma 3Delirium 2Central Nervous System Diseases 2Breast Neoplasms 2Water-Electrolyte Imbalance 1Spinal Cord Neoplasms 1Seizures 1Radiation Injuries 1Neuroinflammatory Diseases 1Neurocognitive Disorders 1Melanoma 1Lung Neoplasms 1Hypoxia 1Hemorrhage 1Gliosarcoma 1Glioma 1Gastrointestinal Neoplasms 1Gangliosidosis, GM1 1Gangliosidoses 1Colorectal Neoplasms 1Cognitive Dysfunction 1Acid-Base Imbalance 1

Interventions

Radiosurgery 3pazopanib 2trametinib 1motexafin gadolinium 1dabrafenib 1alectinib 1Surveys and Questionnaires 1Specimen Handling 1Sodium Chloride 1Patient-Specific Modeling 1Oncolytic Virotherapy 1Observation 1Memantine 1Magnetic Resonance Spectroscopy 1MLN 8237 1Cytoreduction Surgical Procedures 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Sodium Chloride × CNS × Clear all
NCT04899908 2026-03-19

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Brigham and Women's Hospital

Phase 2 Active not recruiting
134 enrolled
BreastCNSDermatologicGastrointestinalThoracic

Brain Neoplasms, Breast Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡